NEW YORK (GenomeWeb) – KineMed and CHDI Foundation today said they are extending their collaboration to characterize and track the pathogenesis of Huntington's disease and to evaluate possible therapeutic interventions.

The collaboration leverages KineMed's translational biomarker platform, which is based on the use of mass spectrometry and mass spectroscopy and interrogates the kinetics of biochemical processes of an entire living organism.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.